Phase I Study of BC008-1A Injection in Patients With Advanced Solid Tumors

Clinical trial NCT06773507 · RECRUITING

Trial details

NCT number: NCT06773507
Sponsor: Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Esophageal Cancers Advanced Non-small Cell Lung Cancer (NSCLC)

Start date: 2025-05-12
Primary completion: 2026-06-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.